ANTI-CARBAMYLATED PROTEIN POSITIVITY PREDICTS DAS28-REMISSION AT 12 MONTHS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE SINGAPORE EARLY ARTHRITIS COHORT

被引：0
|
作者：
Cho, J. [1 ]
Mak, A. [1 ]
Agrawal, S. [1 ]
Dhanasekaran, P. [2 ]
Teoh, L. K. [1 ]
Cheung, P. [1 ]
Lahiri, M. [1 ]
机构：
[1] Natl Univ Singapore Hosp, Singapore, Singapore
[2] Natl Univ Singapore, Singapore, Singapore
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0033
引用
收藏
页码：586 / 587
页数：2
相关论文
共 50 条
  • [1] The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
    Shi, Jing
    van Steenbergen, Hanna W.
    van Nies, Jessica A. B.
    Levarht, E. W. Nivine
    Huizinga, Tom W. J.
    van der Helm-van Mil, Annette H. M.
    Toes, Rene E. M.
    Trouw, Leendert A.
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [2] The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
    Jing Shi
    Hanna W. van Steenbergen
    Jessica A. B. van Nies
    E. W. Nivine Levarht
    Tom W. J. Huizinga
    Annette H. M. van der Helm-van Mil
    René E. M. Toes
    Leendert A. Trouw
    Arthritis Research & Therapy, 17
  • [3] THE SPECIFICITY OF ANTI-CARBAMYLATED PROTEIN ANTIBODIES FOR RHEUMATOID ARTHRITIS IN A SETTING OF EARLY ARTHRITIS
    Shi, J.
    van Steenbergen, H. W.
    van Nies, J. A. B.
    van der Helm-van Mil, A. H. M.
    Huizinga, T. W. J.
    Toes, R. E. M.
    Trouw, L. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A76 - A76
  • [4] The Specificity of Anti-Carbamylated Protein Antibodies for Rheumatoid Arthritis in a Setting of Early Arthritis.
    Shi, Jing
    van Steenbergen, H. W.
    van Nies, J. A. B.
    Levarht, E. W. Nivine
    van der Helm-van Mil, Annette H. M.
    Huizinga, Tom W. J.
    Toes, Rene E. M.
    Trouw, Leendert A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S194 - S194
  • [5] Utility of Anti-Carbamylated Protein Antibodies in the Diagnosis of Early Rheumatoid Arthritis
    Mohamed, Ashraf H.
    Enein, Asmaa
    Abdelsalam, Noha
    Balata, Mona
    Abdellatif, Sameh
    Rizk, Ehsan
    Fathy, Ahmed
    INDIAN JOURNAL OF RHEUMATOLOGY, 2019, 14 (01) : 37 - 41
  • [6] Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept
    Castellanos-Moreira, R.
    Gomez, A.
    Haro, I.
    Ruiz-Esquide, V.
    Marsal, S.
    Sanmarti, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1142 - 1143
  • [7] Predictive Value of Anti-Carbamylated Protein Antibodies in Patients with Early Arthritis
    Regueiro, Cristina
    Peiteado, Diana
    Nuno, Laura
    Villalba, Alejandro
    Pascual-Salcedo, Dora
    Martinez, Ana
    Balsa, Alejandro
    Gonzalez, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [8] Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis
    Piantoni, S.
    Bazzani, C.
    Garrafa, E.
    Fredi, M.
    Cavazzana, I.
    Franceschini, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1144 - 1144
  • [9] Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
    Regueiro, Cristina
    Nuno, Laura
    Ortiz, Ana M.
    Peiteado, Diana
    Villalba, Alejandro
    Pascual-Salcedo, Dora
    Martinez-Feito, Ana
    Gonzalez-Alvaro, Isidoro
    Balsa, Alejandro
    Gonzalez, Antonio
    SCIENTIFIC REPORTS, 2017, 7
  • [10] Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
    Cristina Regueiro
    Laura Nuño
    Ana M. Ortiz
    Diana Peiteado
    Alejandro Villalba
    Dora Pascual-Salcedo
    Ana Martínez-Feito
    Isidoro González-Alvaro
    Alejandro Balsa
    Antonio González
    Scientific Reports, 7
12345